Receptor ligands and imidazoline secretagogues mediate their insulin secretory effects by activating distinct receptor systems in isolated islets

Author： Chan S.L.F.   Morgan N.G.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.350, Iss.2, 1998-06, pp. : 267-272

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The imidazoline I 1 receptor agonist, moxonidine, inhibits insulin secretion from isolated rat islets of Langerhans

By Tsoli E.   Chan S.L.F.   Morgan N.G.  

European Journal of Pharmacology, Vol. 284, Iss. 1, 1995-09 ,pp. : 199-203

Elsevier

Access to resources Recommend Favorite

Imidazoline receptor ligands:cardiovascular applications

By Bousquet P.   Feldman J.   Monassier L.  

Expert Opinion on Emerging Drugs, Vol. 3, Iss. 1, 1998-06 ,pp. : 113-120

Informa Healthcare

Access to resources Recommend Favorite

Pharmacophore Development and SAR Studies of Imidazoline Receptor Ligands

By  

Mini Reviews in Medicinal Chemistry, Vol. 12, Iss. 14, 2012-12 ,pp. : 1542-1555

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitory Effects of Cannabinoid Receptor Ligands on Electrically-Evoked Responses in Rat Isolated Tracheal Ring Segments

By Yousif M.H.M.   Oriowo M.A.  

Pharmacological Research, Vol. 40, Iss. 5, 1999-11 ,pp. : 415-421

Academic Press

Access to resources Recommend Favorite

Effector systems involved in the insulin secretory responses to efaroxan and RX871024 in rat islets of Langerhans

By Mourtada M.   Smith S.A.   Morgan N.G.  

European Journal of Pharmacology, Vol. 350, Iss. 2, 1998-06 ,pp. : 251-258

Elsevier

Access to resources Recommend Favorite